144 ·Filed May 8, 2026
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral
Monitor for actual sale on Form 4, but given the small size and former director status, no material price impact is expected. This is a routine liquidity event.
Final — all horizons settled through T+60d
MRNA ▲ +1.53% at T+60d
NEUTRAL call ✓ call won +1.53% · α vs SPY -1.19% · entry $54.31 → $55.14
T+1d
-2.63%
call -2.63% · α -2.86%
$52.88
settled 5mo ago
T+5d
-7.88%
call -7.88% · α -9.35%
$50.03
settled 5mo ago
T+20d
-12.65%
call -12.65% · α -12.67%
$47.44
settled 4mo ago
T+60d
+1.53%
call +1.53% · α -1.19%
$55.14
settled 8w ago
Price Chart
Loading chart...
Executive Summary
Former director Paul Sagan filed Form 144 to sell 36,759 shares of Moderna, with an estimated value of ~$2.0 million. The sale is small relative to the company's $19.3B market cap and is routine for a former director.
Key Facts
- Paul Sagan, a former director, intends to sell 36,759 shares of Moderna common stock.
- Estimated aggregate market value of the sale is approximately $2,002,786.
- The sale represents a negligible portion of Moderna's $19.3B market capitalization.
- The filing is an advance notice of intent to sell; the sale may not occur.
Financial Impact
Sale of ~$2.0 million in stock by former director.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
30% bullish (30 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-003415 |
| Document: 0001959173-26-003415-index.html | 0001959173-26-003415 |
| Document: 0001959173-26-003415.txt | 0001959173-26-003415 |
18 reports for MRNA
80% Hit rate best @ T+60▲ +14.15%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 30, 2026 2d ago | ANALYST-DOWNGRADE | — | awaiting T+5 | — | — |
Sep 3, 2026 29d ago | ANALYST-DOWNGRADE | $148.87 $143.97 | ▲ +3.29% | ▲ +2.14% | $190.01 (−27.63%) |
Aug 31, 2026 4w ago | Court Ruling | $140.19 $140.33 | ▼ −0.10% | ▼ −0.24% | $190.01 (−35.54%) |
Aug 25, 2026 5w ago | ANALYST-UPGRADE | $158.83 $154.27 | ▼ −2.87% | ▼ −2.33% | $190.01 (+19.63%) |
Aug 19, 2026 6w ago | ANALYST-UPGRADE | $174.38 $149.66 | ▼ −14.18% | ▼ −13.79% | $190.01 (+8.96%) |
Aug 5, 2026 8w ago | 144 | $56.26 $63.67 | ▼ −13.18% | ▼ −12.83% | $190.01 (−237.77%) |
Jul 31, 2026 9w ago | 8-K | $54.82 $59.17 | ▲ +7.94% | ▲ +4.42% | $190.01 (+246.61%) |
Jul 10, 2026 11w ago | 3 | $67.01 $61.82 | ▼ −7.75% | ▼ −6.96% | $190.01 (+183.55%) |
Jul 8, 2026 12w ago | 8-K | $73.80 $67.44 | ▼ −8.62% | ▼ −9.48% | $190.01 (+157.47%) |
Jun 18, 2026 15w ago | 144 | $63.96 $59.75 | ▼ −6.58% | ▼ −4.92% | $190.01 (+197.08%) |
Showing 10 of 18
US Market Status
Market Closed — Opens Mon (65h 6m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access